Products for Research Use Only
RegisterLogin

TQB2916

CAT: 0804-HY-P991556Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P991556Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
TQB2916 is a humanized IgG2 monoclonal antibody agonist targeting CD40. TQB2916 has a significant antitumor activity with CD40 occupancy and immune activation. TQB2916 can be used for advanced solid tumors and lymphomas research[1].
UNSPSC
12352203
Target
TNF Receptor
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
References & Citations
[1]Ba Y, et al. Abstract CT192: A first-in-human phase 1 study of TQB2916, a novel CD40 agonist antibody for advanced malignancies[J]. Cancer Research, 2024, 84 (7_Supplement) : CT192-CT192.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
TNFRSF5/CD40

Related Products

CatalogName
HY-P991395TQB2618

Alternative Products

CatalogName
T9901A-1809-01TQB2916
PTX25628Anti-Human CD40/TNFRSF5 (TQB2916)
MBS1581250-01Research Grade Anti-Human CD40/TNFRSF5 (TQB2916)
A135886Anti-CD40/TNFRSF5 (TQB2916) Biosimilar (Monoclonal, IgG)

Popular Products